AUD 0.46
(7.06%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 | -25.05 Million AUD | -9.8% |
2023 | -22.82 Million AUD | -34.61% |
2022 | -16.95 Million AUD | -55.15% |
2021 | -10.92 Million AUD | -57.96% |
2020 | -6.91 Million AUD | -59.64% |
2019 | -4.33 Million AUD | -4.05% |
2018 | -4.16 Million AUD | -80.06% |
2017 | -2.31 Million AUD | -22.4% |
2016 | -1.88 Million AUD | -177.79% |
2015 | -680.31 Thousand AUD | -15.27% |
2014 | -590.19 Thousand AUD | -28.02% |
2013 | -461.01 Thousand AUD | -10.44% |
2012 | -417.44 Thousand AUD | -3.89% |
2011 | -401.81 Thousand AUD | 0.66% |
2010 | -404.49 Thousand AUD | 21.06% |
2009 | -512.42 Thousand AUD | 81.3% |
2008 | -2.74 Million AUD | -9.71% |
2007 | -2.49 Million AUD | 19.06% |
2006 | -3.08 Million AUD | -101.21% |
2005 | -1.53 Million AUD | -145.11% |
2004 | -625.7 Thousand AUD | 36.33% |
2003 | -982.68 Thousand AUD | -27.43% |
2002 | -771.15 Thousand AUD | 86.04% |
2001 | -5.52 Million AUD | -3558.92% |
2000 | -151 Thousand AUD | -113.47% |
1999 | 1.12 Million AUD | 59.22% |
1998 | 703.97 Thousand AUD | 765.92% |
1997 | -105.71 Thousand AUD | -20.61% |
1996 | -87.65 Thousand AUD | 12.35% |
1995 | -100 Thousand AUD | 9.09% |
1994 | -110 Thousand AUD | -175.0% |
1993 | -40 Thousand AUD | -2100.0% |
1992 | 2000.00 AUD | 100.36% |
1991 | -554 Thousand AUD | -369.49% |
1990 | -118 Thousand AUD | -173.29% |
1989 | 161 Thousand AUD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 FY | -25.23 Million AUD | -10.57% |
2024 Q4 | -18.29 Million AUD | 0.0% |
2024 Q2 | -6.76 Million AUD | 0.0% |
2023 FY | -22.82 Million AUD | -34.61% |
2023 Q2 | -9.68 Million AUD | 0.0% |
2023 Q4 | -13.13 Million AUD | 0.0% |
2022 Q4 | -4.31 Million AUD | 0.0% |
2022 Q2 | -6.61 Million AUD | 0.0% |
2022 FY | -16.95 Million AUD | -55.15% |
2021 Q4 | -6.52 Million AUD | 0.0% |
2021 FY | -10.92 Million AUD | -57.96% |
2021 Q2 | -4.39 Million AUD | 0.0% |
2020 Q2 | -3.24 Million AUD | 0.0% |
2020 FY | -6.91 Million AUD | -59.64% |
2020 Q4 | -3.67 Million AUD | 0.0% |
2019 Q2 | -1.76 Million AUD | 0.0% |
2019 FY | -4.33 Million AUD | -4.05% |
2019 Q4 | -2.31 Million AUD | 0.0% |
2018 FY | -4.16 Million AUD | -80.06% |
2018 Q4 | -1.45 Million AUD | 0.0% |
2018 Q2 | -1.86 Million AUD | 0.0% |
2017 Q2 | -1.11 Million AUD | 0.0% |
2017 Q4 | -639.11 Thousand AUD | 0.0% |
2017 FY | -2.31 Million AUD | -22.4% |
2016 Q4 | -481.09 Thousand AUD | 0.0% |
2016 FY | -1.88 Million AUD | -177.79% |
2016 Q2 | -798.49 Thousand AUD | 0.0% |
2015 FY | -680.31 Thousand AUD | -15.27% |
2015 Q1 | -147.54 Thousand AUD | 0.0% |
2015 Q2 | -383.05 Thousand AUD | -159.61% |
2015 Q3 | -169.82 Thousand AUD | 55.67% |
2015 Q4 | -142.01 Thousand AUD | 16.38% |
2014 Q4 | - AUD | 100.0% |
2014 FY | -590.19 Thousand AUD | -28.02% |
2014 Q3 | -147.54 Thousand AUD | 0.0% |
2014 Q2 | -147.54 Thousand AUD | -28.02% |
2014 Q1 | -115.25 Thousand AUD | 0.0% |
2013 FY | -461.01 Thousand AUD | -10.44% |
2013 Q4 | - AUD | 100.0% |
2013 Q3 | -115.25 Thousand AUD | 0.0% |
2013 Q1 | -104.36 Thousand AUD | 0.0% |
2013 Q2 | -115.25 Thousand AUD | -10.44% |
2012 FY | -417.44 Thousand AUD | -3.89% |
2012 Q4 | - AUD | 100.0% |
2012 Q3 | -104.36 Thousand AUD | 0.0% |
2012 Q2 | -104.36 Thousand AUD | -3.89% |
2012 Q1 | -100.45 Thousand AUD | 0.0% |
2011 Q3 | -100.45 Thousand AUD | 0.0% |
2011 Q2 | -100.45 Thousand AUD | 0.66% |
2011 FY | -401.81 Thousand AUD | 0.66% |
2011 Q4 | - AUD | 100.0% |
2011 Q1 | -101.12 Thousand AUD | 0.0% |
2010 Q4 | - AUD | 100.0% |
2010 FY | -404.49 Thousand AUD | 21.06% |
2010 Q3 | -101.12 Thousand AUD | 0.0% |
2010 Q2 | -101.12 Thousand AUD | 21.06% |
2010 Q1 | -128.1 Thousand AUD | 0.0% |
2009 Q1 | -685.03 Thousand AUD | 0.0% |
2009 Q2 | -128.1 Thousand AUD | 81.3% |
2009 FY | -512.42 Thousand AUD | 81.3% |
2009 Q3 | -128.1 Thousand AUD | 0.0% |
2009 Q4 | - AUD | 100.0% |
2008 Q1 | -624.41 Thousand AUD | 0.0% |
2008 Q2 | -685.03 Thousand AUD | -9.71% |
2008 Q4 | - AUD | 100.0% |
2008 FY | -2.74 Million AUD | -9.71% |
2008 Q3 | -685.03 Thousand AUD | 0.0% |
2007 Q1 | -771.47 Thousand AUD | 0.0% |
2007 Q2 | -624.41 Thousand AUD | 19.06% |
2007 Q3 | -624.41 Thousand AUD | 0.0% |
2007 Q4 | - AUD | 100.0% |
2007 FY | -2.49 Million AUD | 19.06% |
2006 Q4 | - AUD | 100.0% |
2006 Q2 | -771.47 Thousand AUD | -101.21% |
2006 Q3 | -771.47 Thousand AUD | 0.0% |
2006 Q1 | -383.42 Thousand AUD | 0.0% |
2006 FY | -3.08 Million AUD | -101.21% |
2005 Q4 | - AUD | 100.0% |
2005 Q3 | -383.42 Thousand AUD | 0.0% |
2005 Q2 | -383.42 Thousand AUD | -145.11% |
2005 FY | -1.53 Million AUD | -145.11% |
2005 Q1 | -156.42 Thousand AUD | 0.0% |
2004 FY | -625.7 Thousand AUD | 36.33% |
2004 Q3 | -156.42 Thousand AUD | 0.0% |
2004 Q2 | -156.42 Thousand AUD | 36.33% |
2004 Q1 | -245.67 Thousand AUD | 0.0% |
2004 Q4 | - AUD | 100.0% |
2003 Q3 | -245.67 Thousand AUD | 0.0% |
2003 Q1 | -192.78 Thousand AUD | 0.0% |
2003 FY | -982.68 Thousand AUD | -27.43% |
2003 Q4 | - AUD | 100.0% |
2003 Q2 | -245.67 Thousand AUD | -27.43% |
2002 Q4 | - AUD | 100.0% |
2002 FY | -771.15 Thousand AUD | 86.04% |
2002 Q1 | -1.38 Million AUD | 0.0% |
2002 Q2 | -192.78 Thousand AUD | 86.04% |
2002 Q3 | -192.78 Thousand AUD | 0.0% |
2001 FY | -5.52 Million AUD | -3558.92% |
2001 Q1 | -200.41 Thousand AUD | 0.0% |
2001 Q2 | -1.38 Million AUD | -589.19% |
2001 Q3 | -1.38 Million AUD | 0.0% |
2001 Q4 | - AUD | 100.0% |
2000 FY | -151 Thousand AUD | -113.47% |
2000 Q4 | - AUD | 100.0% |
2000 Q3 | -200.41 Thousand AUD | 0.0% |
2000 Q1 | 441.79 Thousand AUD | 0.0% |
2000 Q2 | -200.41 Thousand AUD | -145.36% |
1999 Q2 | 441.79 Thousand AUD | 35.71% |
1999 FY | 1.12 Million AUD | 59.22% |
1999 Q4 | - AUD | -100.0% |
1999 Q3 | 441.79 Thousand AUD | 0.0% |
1999 Q1 | 325.53 Thousand AUD | 0.0% |
1998 Q4 | 325.53 Thousand AUD | 0.0% |
1998 Q3 | 325.53 Thousand AUD | 0.0% |
1998 Q2 | 325.53 Thousand AUD | 628.8% |
1998 FY | 703.97 Thousand AUD | 765.92% |
1998 Q1 | -61.56 Thousand AUD | 0.0% |
1997 Q3 | -61.56 Thousand AUD | 0.0% |
1997 Q1 | -52.78 Thousand AUD | 0.0% |
1997 Q4 | - AUD | 100.0% |
1997 FY | -105.71 Thousand AUD | -20.61% |
1997 Q2 | -61.56 Thousand AUD | -16.62% |
1996 Q3 | -52.78 Thousand AUD | 0.0% |
1996 Q1 | -55.75 Thousand AUD | 0.0% |
1996 Q4 | -52.78 Thousand AUD | 0.0% |
1996 FY | -87.65 Thousand AUD | 12.35% |
1996 Q2 | -52.78 Thousand AUD | 5.31% |
1995 Q3 | -55.75 Thousand AUD | 0.0% |
1995 Q4 | -55.75 Thousand AUD | 0.0% |
1995 Q2 | -55.75 Thousand AUD | 9.72% |
1995 Q1 | -61.75 Thousand AUD | 0.0% |
1995 FY | -100 Thousand AUD | 9.09% |
1994 Q2 | -61.75 Thousand AUD | -135.24% |
1994 Q1 | -26.25 Thousand AUD | 0.0% |
1994 Q4 | -61.75 Thousand AUD | 0.0% |
1994 FY | -110 Thousand AUD | -175.0% |
1994 Q3 | -61.75 Thousand AUD | 0.0% |
1993 Q2 | -26.25 Thousand AUD | -10600.0% |
1993 Q4 | -26.25 Thousand AUD | 0.0% |
1993 FY | -40 Thousand AUD | -2100.0% |
1993 Q3 | -26.25 Thousand AUD | 0.0% |
1993 Q1 | 250.00 AUD | 0.0% |
1992 FY | 2000.00 AUD | 100.36% |
1992 Q1 | -224.5 Thousand AUD | 0.0% |
1992 Q2 | 250.00 AUD | 100.11% |
1992 Q4 | 250.00 AUD | 0.0% |
1992 Q3 | 250.00 AUD | 0.0% |
1991 Q3 | -224.5 Thousand AUD | 0.0% |
1991 Q4 | -224.5 Thousand AUD | 0.0% |
1991 Q1 | -59.25 Thousand AUD | 0.0% |
1991 Q2 | -224.5 Thousand AUD | -278.9% |
1991 FY | -554 Thousand AUD | -369.49% |
1990 Q2 | -59.25 Thousand AUD | -194.42% |
1990 Q3 | -59.25 Thousand AUD | 0.0% |
1990 Q4 | -59.25 Thousand AUD | 0.0% |
1990 FY | -118 Thousand AUD | -173.29% |
1990 Q1 | 62.75 Thousand AUD | 0.0% |
1989 Q2 | 62.75 Thousand AUD | 0.0% |
1989 FY | 161 Thousand AUD | 0.0% |
1989 Q3 | 62.75 Thousand AUD | 0.0% |
1989 Q4 | 62.75 Thousand AUD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
AdAlta Limited | -5.26 Million AUD | -376.278% |
Acrux Limited | -9.83 Million AUD | -154.828% |
Actinogen Medical Limited | -12.83 Million AUD | -95.185% |
AnteoTech Limited | -11.72 Million AUD | -113.7% |
Argenica Therapeutics Limited | -5.67 Million AUD | -341.878% |
Arovella Therapeutics Limited | -7.19 Million AUD | -248.389% |
Anatara Lifesciences Ltd | -1.45 Million AUD | -1617.451% |
Alterity Therapeutics Limited | -19.6 Million AUD | -27.845% |
Amplia Therapeutics Limited | -4.42 Million AUD | -466.326% |
Avecho Biotechnology Limited | -4.58 Million AUD | -446.061% |
Bio-Gene Technology Limited | -3.06 Million AUD | -718.289% |
Biome Australia Limited | -1.91 Million AUD | -1209.809% |
Biotron Limited | -5.15 Million AUD | -386.487% |
Botanix Pharmaceuticals Limited | -14.69 Million AUD | -70.476% |
BTC Health Limited | 1.05 Million AUD | 2474.689% |
Chimeric Therapeutics Limited | -12.3 Million AUD | -103.578% |
CSL Limited | 5.64 Billion AUD | 100.444% |
Clarity Pharmaceuticals Ltd | -44.8 Million AUD | 44.064% |
Clinuvel Pharmaceuticals Limited | 49.14 Million AUD | 150.988% |
Cynata Therapeutics Limited | -8.8 Million AUD | -184.514% |
EZZ Life Science Holdings Limited | 9.71 Million AUD | 357.908% |
Hexima Limited | -1 Million AUD | -2384.242% |
Island Pharmaceuticals Limited | -2.87 Million AUD | -772.014% |
Immuron Limited | -5.8 Million AUD | -331.982% |
Immutep Limited | -44.93 Million AUD | 44.234% |
Imugene Limited | -140.93 Million AUD | 82.218% |
Invex Therapeutics Ltd | -2.13 Million AUD | -1074.516% |
Memphasys Limited | -2.7 Million AUD | -826.767% |
Nanollose Limited | -1.24 Million AUD | -1905.064% |
Neuren Pharmaceuticals Limited | 225.96 Million AUD | 111.09% |
Noxopharm Limited | -7.53 Million AUD | -232.578% |
NeuroScientific Biopharmaceuticals Limited | -2.05 Million AUD | -1118.529% |
Nyrada Inc. | -4.56 Million AUD | -449.517% |
Orthocell Limited | -11.68 Million AUD | -114.532% |
PharmAust Limited | -6.65 Million AUD | -276.35% |
Patrys Limited | -3.53 Million AUD | -608.074% |
Paradigm Biopharmaceuticals Limited | -65.11 Million AUD | 61.513% |
Proteomics International Laboratories Limited | -7.23 Million AUD | -246.534% |
Prescient Therapeutics Limited | -7.18 Million AUD | -248.71% |
PYC Therapeutics Limited | -38.85 Million AUD | 35.508% |
Race Oncology Limited | -13.38 Million AUD | -87.285% |
Radiopharm Theranostics Limited | -47.2 Million AUD | 46.918% |
Recce Pharmaceuticals Ltd | -22.05 Million AUD | -13.643% |
Starpharma Holdings Limited | -15.15 Million AUD | -65.313% |
Telix Pharmaceuticals Limited | - AUD | Infinity% |
Tissue Repair Ltd | -4.87 Million AUD | -413.947% |
Zelira Therapeutics Limited | -5.93 Million AUD | -322.008% |